Results 101 to 110 of about 44,369 (290)

Comparison of Two Pulsed Field Ablation Systems for Atrial Fibrillation: One‐Year Outcomes From a Multicenter Registry

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background While various pulsed field ablation (PFA) systems for atrial fibrillation (AF) ablation have become available in recent years, data comparing long‐term efficacy outcomes remain limited. Purpose To compare long‐term efficacy outcomes of two commercially available PFA systems to perform pulmonary vein isolation (PVI) for AF in a ...
Marisa van der Graaf, Bob G. S. Abeln, Jippe C. Balt, Suneet Mittal, Bradley P. Knight, Melanie A. Gunawardene, Bradley Wilsmore, Amardeep Amardeep, Tim Harloff, Max Liebregts, Michael M. Malaty, Dan L. Musat, Graham Peigh, Supreet Singh, Maurits C. E. F. Wijffels, Stephan Willems, Nishant Verma, Vincent F. van Dijk, Lucas V. A. Boersma   +18 more
wiley   +1 more source

Investigational antiarrhythmic agents: promising drugs in early clinical development

, 2017
Introduction: Although there have been important technological advances for the treatment of cardiac arrhythmias (e.g., catheter ablation technology), antiarrhythmic drugs (AADs) remain the cornerstone therapy for the majority of patients with ...
Shokoufeh Ghezelbash, Dobromir Dobrev, Heijman, Jordi; id_orcid, Ghezelbash, Shokoufeh, Jordi Heijman, Heijman, Jordi, Dobrev, Dobromir   +6 more
core   +1 more source

Antiarrhythmic therapy for narrow QRS supraventricular tachyarrhythmias in newborns and infants in the first year of life: Potent tools to be handled with care

Indian Pacing and Electrophysiology Journal
Supraventricular tachyarrhythmias pose a significant challenge in neonates and infants, particularly within the first year of life, where prompt and effective management is crucial.
Giovanni Domenico Ciriello, Davide Sorice, Antonio Orlando, Giovanni Papaccioli, Diego Colonna, Anna Correra, Emanuele Romeo, Raffaella Esposito, Marina De Marco, Veronica Diana, Mario Giordano, Ludovica Spinelli Barrile, Maria Giovanna Russo, Berardo Sarubbi   +13 more
doaj   +1 more source

Invasive Assessment of Right Ventricular Dysfunction Predicts Periprocedural Outcomes in Patients Undergoing Unplanned Ventricular Tachycardia Ablation

Journal of Cardiovascular Electrophysiology, EarlyView.
Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno, Sai Prasad Ramachandran, V. Karthik, Mendpara Vaidehi, Andrew Cesmat, Joseph Sipko, Bryan Baranowski, Mandeep Bhargava, Thomas D. Callahan, Mina K. Chung, Thomas Dresing, Ayman A. Hussein, Mohamed Kanj, Arshneel Kochar, David O. Martin, Walid I. Saliba, Tyler L. Taigen, Niraj Varma, Koji Higuchi, Justin Z. Lee, Oussama M. Wazni, Andres Carmona Rubio, Pasquale Santangeli, Jakub Sroubek   +23 more
wiley   +1 more source

Antiarrhythmic Treatment in Heart Failure

<jats:title>Abstract   </jats:title><jats:sec> <jats:title>Purpose of Review</jats:title> <jats:p>Arrhythmias are common in patients with heart failure (HF) and are associated with a ...
Eckardt, Lars, Ellermann, Christian, Könemann, Hilke, Frommeyer, Gerrit, Güler-Eren, Sati   +4 more
core   +1 more source

Comparative Efficacy of Continuous Versus Patch ECG Monitoring in Detecting Atrial Fibrillation Recurrence Post Catheter Ablation: Insights From the REAL‐AF Registry

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Effective monitoring of atrial fibrillation (AF) recurrence following catheter ablation is crucial for optimizing patient outcomes. Various monitoring strategies exist, but effectiveness comparisons remain underexplored. Objective This study compares the recurrence of atrial arrhythmias detected by continuous versus patch ECG ...
Chinmaya Mareddy, Yashendra Sethi, Gurpreet Johal, Manasvi Gupta, Joshua Silverstein, Amit Thosani, Paul Zei, Linda Justice, Susan M. Bezenek, Jorge Romero, Mohammad Al Jazayeri, Saumil Oza, Matthew J. Singleton, Charles Te, Matthew Sellers, Jordan Leyton Mange, Sandeep Bansal, Huy Phan, Nicholas Costa, Matthew Sackett, Jose Silva, Julia McHugh, Rich Kuk, Daniela Hincapie‐Tabares, Jose Osorio   +24 more
wiley   +1 more source

PVC Variability and Impact on Meeting Expert Consensus Cutoffs of ≥ 10 000 PVCs/Day and ≥ 15% PVCs

Journal of Cardiovascular Electrophysiology, EarlyView.
14‐day Zio® (iRhythm) datasets of 606 patients between December 2018 and January 2019 who had at least one day of ≥10,000 PVCs were acquired. Of these patients, a subcohort of 325 patients who had at least one day of ≥15% PVCs was generated. In both groups, analyses were carried out showing that longer duration monitoring increased sensitivity for ...
Richard S. Amara, Justin Brilliant, Jason Appelbaum, Ameer Abutaleb, Rama Vunnam, Stephen R. Shorofsky, Jeffrey N. Rottman, Ardit Kacorri, Timm M. Dickfeld   +8 more
wiley   +1 more source

Pediatric antiarrhythmics and toxicity: A clinical review

Journal of the American College of Emergency Physicians Open
Antiarrhythmic medications are fundamental in the acute and chronic management of pediatric arrhythmias. Particularly in the pediatric patient population, associated antiarrhythmic toxicities represent important potential adverse effects.
Alexandra T. Geanacopoulos, Benjamin Zielonka, Miriam T. Fox, Sarah Kerr, Kristina D. Chambers, Robert Przybylski, Michele M. Burns   +6 more
doaj   +1 more source

Antiarrhythmic drug therapy during cardiopulmonary resuscitation:Should we use it?

, 2018
Purpose of review The optimal antiarrhythmic drug therapy (amiodarone or lidocaine) in the treatment of ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) cardiac arrest that is refractory to defibrillation is uncertain.
Jasmeet Soar, Soar, Jasmeet
core   +1 more source

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL‐23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Ulcerative colitis (UC) and Crohn's disease (CD) are increasingly prevalent in the Asia Pacific region, necessitating updated, region‐specific guidance on advanced therapies. Targeted small molecule agents, such as filgotinib, tofacitinib, upadacitinib, etrasimod, and ozanimod; and the IL‐23 p19 inhibitors (guselkumab, mirikizumab ...
Choon Jin Ooi, Khoon Lin Ling, Julajak Limsrivilai, Shu‐Chen Wei, Joyce Wing Yan Mak, Taku Kobayashi, Luan Minh Dang, Rupert W. Leong, Huiyu Lin, Meng‐Tzu Weng, Wan Chee Ong, Vineet Ahuja, Satimai Aniwan, Ryota Hokari, Wei Jie Jonathan Lee, Alex Hwong‐Ruey Leow, Wai‐Keung Leung, Wee‐Chian Lim, Govind Makharia, Katsuyoshi Matsuoka, Nazri Mustaffa, Siew‐Chien Ng, Mathew Philip, Pises Pisespongsa, Raja Affendi Raja Ali, Zhi Hua Ran, Marcellus Simadibrata, Jose Sollano, Malcolm Tan, Hang Dao Viet, Nik Razima Wan Ibrahim, Kai Chun Wu, Byong Duk Ye, Ida Hilmi, Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN‐IBD)   +34 more
wiley   +1 more source